back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-04 16:04 Tx date 2026-04-27 |
$NGEN
NervGen Pharma Corp. |
Vendola, Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,183,047
+812,002 vol $3.92 each |
812,002 | |
| Filed 2026-06-04 15:57 Tx date 2026-04-27 |
$NGEN
NervGen Pharma Corp. |
Vendola, Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-03 10:00 Tx date 2026-05-26 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: PFP Biosciences Holdings LLC (Control or Direction)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$2,944,000
+800,000 vol $3.68 each |
5,800,000 | |
| Filed 2026-06-03 09:59 Tx date 2026-05-26 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: PFP Biosciences Holdings LLC (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$2,000,000
+800,000 vol $2.50 each |
10,800,000 | |
| Filed 2026-06-01 09:10 Tx date 2026-05-27 |
$NGEN
NervGen Pharma Corp. |
Ruffolo, John
4 - Director of Issuer
Holder: John Ruffolo (in trust for Rome Ruffolo) (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33.22
+16 vol $2.08 each |
843 | |
| Filed 2026-06-01 09:07 Tx date 2026-05-27 |
$NGEN
NervGen Pharma Corp. |
Ruffolo, John
4 - Director of Issuer
Holder: Spartacus (2022) Family Trust No. 2 (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,234
+8,775 vol $2.08 each |
51,328 | |
| Filed 2026-06-01 09:07 Tx date 2026-05-27 |
$NGEN
NervGen Pharma Corp. |
Ruffolo, John
4 - Director of Issuer
Holder: Spartacus (2022) Family Trust No. 2 (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,234
+8,775 vol $2.08 each |
||
| Filed 2026-05-31 13:00 Tx date 2026-05-13 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$4,572,970
+1,146,108 vol $3.99 each |
2,253,999 | |
| Filed 2026-05-04 10:45 Tx date 2026-04-29 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,912
+4,250 vol $3.74 each |
1,179,782 | |
| Filed 2026-04-08 15:25 Tx date 2026-04-02 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,150
-5,000 vol $4.23 each |
37,758 | |
| Filed 2026-04-08 15:24 Tx date 2026-04-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,914
-10,000 vol $4.19 each |
27,758 | |
| Filed 2026-03-13 11:48 Tx date 2026-03-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,924
-5,000 vol $3.98 each |
42,758 | |
| Filed 2026-03-02 11:04 Tx date 2026-02-26 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,514
-5,000 vol $4.10 each |
57,758 | |
| Filed 2026-03-02 11:03 Tx date 2026-02-26 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,639
-5,000 vol $4.13 each |
62,758 | |
| Filed 2026-03-02 11:00 Tx date 2026-03-02 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,517
-10,000 vol $3.85 each |
47,758 | |
| Filed 2026-02-23 12:36 Tx date 2026-02-20 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,914
-9,980 vol $4.30 each |
67,758 | |
| Filed 2026-02-23 12:35 Tx date 2026-02-19 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86.00
-20 vol $4.30 each |
77,738 | |
| Filed 2026-02-23 12:34 Tx date 2026-02-19 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,773
-10,000 vol $4.18 each |
77,758 | |
| Filed 2026-02-23 12:33 Tx date 2026-02-18 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,312
-10,000 vol $4.13 each |
87,758 | |
| Filed 2026-02-16 13:05 Tx date 2026-02-12 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,958
-10,000 vol $4.00 each |
97,758 |